Page 215«..1020..214215216217..220230..»

Texan on a mission to do everything on her bucket list after receiving ALS diagnosis – KVUE.com

Posted: Published on September 20th, 2022

Sara Wheeler discovered she had a progressive neurodegenerative disease on Mother's Day 2021. Continue reading

Posted in ALS Treatment | Comments Off on Texan on a mission to do everything on her bucket list after receiving ALS diagnosis – KVUE.com

Hospital-Treated Infections and Alzheimer’s Risk – Healthline

Posted: Published on September 20th, 2022

Infections treated in the hospital in early adulthood and mid-life may increase the risk of developing Alzheimers disease and Parkinsons disease later in life. Continue reading

Posted in ALS Treatment | Comments Off on Hospital-Treated Infections and Alzheimer’s Risk – Healthline

Tiziana Life Sciences Announces Grant received by the Brigham and Womens Hospital to Explore the Use of Intranasal anti-CD3 mAb in Amyotrophic Lateral…

Posted: Published on September 20th, 2022

Tiziana Life Sciences Ltd. - Prestigious ALS Association grant awarded to BWH to study the utility of an intranasal anti-CD3 monoclonal antibody in an animal model of Amyotrophic Lateral Sclerosis - NEW YORK, Sept. Continue reading

Posted in ALS Treatment | Comments Off on Tiziana Life Sciences Announces Grant received by the Brigham and Womens Hospital to Explore the Use of Intranasal anti-CD3 mAb in Amyotrophic Lateral…

ALS advocate Greg Gowe dies after a fierce fight with the disease – North Shore News

Posted: Published on September 20th, 2022

North Vancouver's Greg Gowe built an organization tasked with ending ALS, all while battling against the devastating disease himself Greg Gowe was adamant that he was going to compose his final tweet, even though it took all his remaining strength to do so. The North Vancouver man had built a strong following on Twitter since his 2019 diagnosis with amyotrophic lateral sclerosis, the progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control Continue reading

Posted in ALS Treatment | Comments Off on ALS advocate Greg Gowe dies after a fierce fight with the disease – North Shore News

5 for Good: Ray Bourque teams up with Frates family to fight ALS – WCVB Boston

Posted: Published on September 20th, 2022

Boston Bruins legend Ray Bourque was born Dec. 28, 1960.On the same day in 1984, Pete Frates was born.The inspiration for the ALS ice bucket challenge, Pete Frates was famously the captain of the Boston College baseball team, but his mother Nancy Frates said he loved hockey too."Pete was on skates by age four or five, and his hero was the captain of the Bruins," she said.Bourque remembered a meeting he had with Pete Frates shortly after he was diagnosed with ALS.We were talking about how can we raise money for ALS," Bourque said. "You just couldn't help yourself to be inspired and to be so impressed with this young man."His words, Nancy Frates said Continue reading

Posted in ALS Treatment | Comments Off on 5 for Good: Ray Bourque teams up with Frates family to fight ALS – WCVB Boston

‘I want to keep going,’ Speech therapist with ALS continues teaching, inspired by students – CBS Boston

Posted: Published on September 20th, 2022

By Juli McDonald Updated on: September 16, 2022 / 7:04 AM / CBS Boston Speech therapist diagnosed with ALS continues to teach ACTON - Together at their dining room table, Belinda Paul sees her team. There's so much love in this Acton home, and laughter; A family to quite literally, lean on Continue reading

Posted in ALS Treatment | Comments Off on ‘I want to keep going,’ Speech therapist with ALS continues teaching, inspired by students – CBS Boston

How a Clinical Trial Brought Meaning and Hope to Our ALS Fight |… – ALS News Today

Posted: Published on September 20th, 2022

After my husband, Jeff, died from ALS in 2020, I found a video hed taken by mistake right around the time of his diagnosis. Hed left his phone on and unintentionally recorded three minutes of his expression while sitting in our yard in the November cold, drawing on a cigar and staring, squinting, at the water. Continue reading

Posted in ALS Treatment | Comments Off on How a Clinical Trial Brought Meaning and Hope to Our ALS Fight |… – ALS News Today

Myocardial Infarction With Ventricular Wall Aneurysm: A Case Report – Cureus

Posted: Published on September 12th, 2022

A ventricular aneurysm is a dreaded myocardial infarction complication that develops in post-myocardial infarction's remodeling phase. There can be true aneurysms and false aneurysms; the latter constitute only of pericardial layer; it lacks myocardial and epicardial elements [1]. Continue reading

Posted in Ventricular Remodeling | Comments Off on Myocardial Infarction With Ventricular Wall Aneurysm: A Case Report – Cureus

A Study of Vitamin D and Its Correlation With Severity and Complication of Congestive Heart Failure: A Systematic Review – Cureus

Posted: Published on September 12th, 2022

Congestive heart failure (CHF) is a cardiac dysfunction syndrome characterized by a reduced left ventricular ejection fraction (LVEF) associated with water and sodium retention. Muscle weakness and early fatigue are the two primary symptoms of CHF patients. The prevalence of CHF is approximately 1% to 3% in western societies. Continue reading

Posted in Ventricular Remodeling | Comments Off on A Study of Vitamin D and Its Correlation With Severity and Complication of Congestive Heart Failure: A Systematic Review – Cureus

Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit Used in Ongoing HF-REVERT Phase 2 Clinical Study – Business Wire

Posted: Published on September 12th, 2022

HANOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the CE marking of its PCR kit which measures circulating microRNA-132 (miR-132) levels in the blood of patients receiving the companys lead candidate CDR132L, an oligonucleotide-based miR-132 inhibitor. The company is currently conducting its Phase 2 clinical study, HF-REVERT (NCT05350969), to evaluate the safety and efficacy of CDR132L in patients with heart failure and reduced left ventricular ejection fraction (LVEF) after a myocardial infarction. By using the CardiorHealth miR-132 PCR kit, Cardior ensures consistent measurement of miR-132 levels following CDR132L treatment across all clinical trial centers as an indicator of the target engagement and the compounds mechanism of action. Continue reading

Posted in Ventricular Remodeling | Comments Off on Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit Used in Ongoing HF-REVERT Phase 2 Clinical Study – Business Wire

Page 215«..1020..214215216217..220230..»